Pathology Services Market Valued at USD 18.8 Billion in 2025 | ACL Laboratories, AmeriPath, BioReference Health Lead – Fact.MR

The global pathology services market is forecast to reach USD 36 billion by 2035, up from USD 18.8 billion in 2025. During the forecast period, the industry is projected to register at a CAGR of 6.7%. This expansion is driven by the rising prevalence of chronic diseases, an aging global population, and technological advancements in diagnostic workflows. The United States, China, and Japan are key growth regions, with hospitals dominating as the primary end-users and disease diagnostics leading as the core application segment. Despite robust growth prospects, challenges such as skilled workforce shortages, high capital costs, and stringent regulatory requirements could impede progress, necessitating continuous innovation and strategic investments to sustain market momentum.

Pathology Services Market Technology Development:

Technological advancements are revolutionizing the pathology services industry, enhancing diagnostic accuracy and operational efficiency. The adoption of digital pathology platforms, AI-enabled image analysis, and cloud-based reporting systems has streamlined workflows, reduced turnaround times, and improved collaboration among pathologists. Innovations in molecular diagnostics and high-throughput automation are expanding the scope of pathology into precision medicine, particularly in oncology and infectious disease monitoring. For instance, AI-driven histopathology tools are improving diagnostic precision, while telepathology platforms enable remote case reviews, addressing workforce shortages in underserved regions. Companies are investing in robotics and automated sample processing to handle high test volumes, with Japan leading in robotic slide processors and automated analyzers. These advancements align with the growing demand for personalized diagnostics and data-driven healthcare, positioning early adopters for a competitive edge as technology costs decline and scalability improves.

Pathology Services Market Demand and Impact Analysis:

The demand for pathology services is fueled by the global rise in chronic and lifestyle-related diseases, including cancer, diabetes, and cardiovascular disorders, which affect over 1.5 billion people worldwide. Public health screening programs and growing patient awareness of early detection have increased test volumes by 15-20% annually in key markets like the United States and China. The aging population, projected to constitute 16% of the global population by 2035, is a significant driver, as elderly individuals require frequent diagnostic monitoring. Emerging economies, such as India and China, are witnessing a 25-30% rise in diagnostic demand due to urbanization and healthcare infrastructure investments. Government initiatives, such as expanded insurance coverage and preventive care programs, further boost accessibility. However, challenges like workforce shortages, affecting 30% of diagnostic facilities globally, and high equipment costs could limit growth in low-income regions. The shift toward home-based sample collection and telepathology is creating opportunities for providers to enhance accessibility and meet patient expectations for faster, more convenient diagnostics.

Pathology Services Market Analysis by Top Investment Segments:

The pathology services market is segmented by application (disease diagnostics, drug discovery and development, others), end-user (hospitals, research laboratories, diagnostic laboratories, others), and region (North America, Latin America, Western Europe, East Asia, South Asia & Pacific, Eastern Europe, Middle East & Africa). Disease diagnostics holds the largest share, accounting for over 60% of the market in 2025, driven by the need for early detection of chronic and infectious diseases. This segment is expected to grow at a 7% CAGR through 2035, fueled by advancements in molecular testing and genomic profiling. Hospitals dominate the end-user segment with a 55% share, supported by their comprehensive diagnostic capabilities and integration with surgical and oncology workflows. Investments in digital pathology and AI tools are particularly attractive in this segment, as hospitals prioritize real-time reporting and electronic health record integration. Diagnostic laboratories are emerging as high-growth opportunities due to their focus on specialized testing and faster turnaround times. Regionally, North America and East Asia offer the highest returns, with China’s market projected to grow at a 7.8% CAGR due to policy-driven screening programs and telepathology adoption.

Full Market Report available for delivery. For purchase or customization, please request here: https://www.factmr.com/connectus/sample?flag=S&rep_id=8361

Pathology Services Market Across Top Countries:

The pathology services market exhibits distinct regional dynamics, with key countries driving growth:

1.China leads with a 7.8% CAGR, propelled by state-backed healthcare reforms, early cancer detection programs, and telepathology adoption in rural areas. Urban hospitals are integrating AI-based histopathology, enhancing diagnostic efficiency.

2.United States, valued at approximately USD 7 billion in 2025, grows at a 5.9% CAGR, driven by high chronic disease prevalence, widespread insurance coverage, and decentralized care models like mobile labs.

3.Japan, also at a 5.9% CAGR, benefits from its aging population and robotics-enabled pathology workflows, with automated systems reducing errors and addressing workforce shortages.

4.Germany, France, and the UK in Western Europe collectively hold a 25% global share, supported by regulatory standardization and early detection programs emphasizing molecular testing.

5.India is a high-growth market, driven by increasing diagnostic demand in urban centers and public-private partnerships expanding rural access. These countries underscore the market’s global diversity, with APAC leading due to demographic shifts and infrastructure investments.

Leading Pathology Services Companies and Their Industry Share:

The pathology services market is competitive, with key players like ACL Laboratories, AmeriPath, BioReference Health LLC, Sonic Healthcare, and Unilabs Corporation holding over 40% of the market share. ACL Laboratories and AmeriPath lead in hospital-based diagnostics, leveraging extensive test menus and digital pathology integration. BioReference Health excels in high-volume testing and telepathology services, while Sonic Healthcare dominates through global acquisitions and AI-driven diagnostics. Unilabs, with operations in over 30 countries, focuses on cutting-edge technologies and conducts 600 million tests annually. Recent developments, such as Eurofins Scientific’s acquisition of SYNLAB’s Spanish operations in March 2025, highlight market consolidation trends. Regional players like Krsnaa Diagnostics in India are gaining traction in price-sensitive markets, but multinationals maintain dominance through innovation, regulatory compliance, and scale.

Pathology Services Market Historic and Future Pathway Analysis:

From 2020 to 2024, the pathology services market grew from USD 14.5 billion to USD 18.8 billion at a CAGR of 6.5%, driven by post-pandemic diagnostic demand and digital pathology adoption. The market faced challenges from supply chain disruptions and workforce shortages but recovered through automation and telepathology investments. Looking ahead, the market is projected to reach USD 36 billion by 2035 at a 6.7% CAGR, propelled by aging populations, chronic disease prevalence, and AI integration. Emerging markets in East Asia and South Asia & Pacific will drive volume growth, while North America and Europe focus on high-value specialized testing. Challenges like regulatory compliance costs and skilled labor shortages require sustained investments in training and technology. Providers must prioritize partnerships, such as public-private collaborations, and innovative service models like home-based testing to capture growth opportunities.

Pathology Services Industry News:

Recent developments underscore the industry’s dynamic evolution:

1.In January 2025, SYNLAB strengthened its position as a European leader by integrating cutting-edge AI diagnostics across its network, conducting 600 million tests annually.

2.In April 2025, Eurofins Scientific acquired SYNLAB’s Spanish clinical diagnostics operations, enhancing its molecular testing capabilities and market presence.

3.In 2024, Sonic Healthcare launched AI-powered histopathology tools, reducing diagnostic turnaround times by 20%. These initiatives reflect the industry’s focus on digital transformation, consolidation, and accessibility, aligning with global healthcare demands for precision and efficiency.

Explore More Related Studies Published by Fact.MR Research

Hypodermic Needles Market- https://www.factmr.com/report/hypodermic-needles-market

Needle-free IV Connectors Market- https://www.factmr.com/report/needle-free-iv-connectors-market

Sterilization Monitoring Technologies Market- https://www.factmr.com/report/sterilization-monitoring-technologies-market

Beta Interferon Market- https://www.factmr.com/report/beta-interferon-market

Dissolvable Stitches Market- https://www.factmr.com/report/dissolvable-stitches-market

About Fact.MR:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Contact:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Sales Team: sales@factmr.com

Follow Us: LinkedIn | Twitter | Blog